Diaz-Martinez, J.; Kotzker, W.; Mendoza-Hernandez, M.A.; Gadh, R.S.; Hernandez-Fuentes, G.A.; Bañuelos, A.; Guzmán-Esquivel, J.; Hong, A.; Delgado-Enciso, O.G.; Geyer-Roberts, E.;
et al. Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic. Pharmaceutics 2024, 16, 920.
https://doi.org/10.3390/pharmaceutics16070920
AMA Style
Diaz-Martinez J, Kotzker W, Mendoza-Hernandez MA, Gadh RS, Hernandez-Fuentes GA, Bañuelos A, Guzmán-Esquivel J, Hong A, Delgado-Enciso OG, Geyer-Roberts E,
et al. Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic. Pharmaceutics. 2024; 16(7):920.
https://doi.org/10.3390/pharmaceutics16070920
Chicago/Turabian Style
Diaz-Martinez, Janet, Wayne Kotzker, Martha A. Mendoza-Hernandez, Rajdeep S. Gadh, Gustavo A. Hernandez-Fuentes, Andrew Bañuelos, José Guzmán-Esquivel, Angelina Hong, Osiris G. Delgado-Enciso, Elizabeth Geyer-Roberts,
and et al. 2024. "Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic" Pharmaceutics 16, no. 7: 920.
https://doi.org/10.3390/pharmaceutics16070920
APA Style
Diaz-Martinez, J., Kotzker, W., Mendoza-Hernandez, M. A., Gadh, R. S., Hernandez-Fuentes, G. A., Bañuelos, A., Guzmán-Esquivel, J., Hong, A., Delgado-Enciso, O. G., Geyer-Roberts, E., Martinez-Fierro, M. L., Rodriguez-Sanchez, I. P., Garza-Veloz, I., Canseco-Ávila, L. M., & Delgado-Enciso, I.
(2024). Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic. Pharmaceutics, 16(7), 920.
https://doi.org/10.3390/pharmaceutics16070920
